TCICL(600281)

Search documents
华阳新材:华阳新材关于参加山西辖区上市公司2024年投资者网上集体接待日暨年报业绩说明会情况的公告
2024-05-21 09:06
证券代码:600281 证券简称:华阳新材 公告编号:临 2024- 040 山西华阳新材料股份有限公司 关于参加山西辖区上市公司 2024 年投资者 网上集体接待日暨年报业绩说明会情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、本次集体接待日暨年报业绩说明会基本情况 山西华阳新材料股份有限公司(以下简称:"公司")于 2024 年 5 月 20 日(星 期一)15:00-17:00 在"全景路演"网站(http://rs.p5w.net)通过网络在线交流 的方式, 参加了"山西辖区上市公司 2024 年投资者网上集体接待日暨年报业绩说 明会"活动(以下简称:"本次活动"),公司董事长、总经理、独立董事、董事 会秘书、财务总监、证券事务代表出席了本次活动,回答了投资者关注的问题。 二、本次活动投资者提出的主要问题及公司的回复情况 1、公司是否将市值管理列为公司负责人或负责部门业绩考核范畴?比重多少? 公司回复:尊敬的投资者,您好!公司高度重视市值管理工作,立足提升经营业 绩,保护全体股东利益,尤其做好中小股东合 ...
华阳新材:华阳新材2023年年度股东大会会议资料
2024-05-17 09:47
山西华阳新材料股份有限公司 2023 年年度股东大会会议资料 二零二四年五月 | 一、山西华阳新材料股份有限公司 | | | | 2023 | | | | | | 年年度股东大会会议须知 - 3 - | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 二、山西华阳新材料股份有限公司 | | | | 2023 | | | | | | 年年度股东大会表决办法 - 5 - | | | | 三、山西华阳新材料股份有限公司 | 2023 | | | | | | | | | 年年度股东大会议案 - 5 - | | | | 1、公司 2023 | 年度董事会工作报告 | | 6 - | | | | | | | | | - | | 2、公司 2023 | 年度独立董事述职报告 | - 14 - | | | | | | | | | | | | 3、公司 | 年度监事会工作报告 | | | | | 2023 | | 29 - | | | - | | | 4、公司 2023 | 年年度报告及摘要 | | | ...
华阳新材:华阳新材关于召开2023年年度股东大会的提示性公告
2024-05-17 09:47
证券代码:600281 证券简称:华阳新材 公告编号:2024-039 山西华阳新材料股份有限公司 关于召开 2023 年年度股东大会的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 一、 召开会议的基本情况 (一)股东大会类型和届次 2023 年年度股东大会 的方式 (四)现场会议召开的日期、时间和地点 召开的日期时间:2024 年 5 月 23 日 14 点 30 分 召开地点:公司会议室 (五)网络投票的系统、起止日期和投票时间。 网络投票系统:上海证券交易所股东大会网络投票系统 网络投票起止时间:自 2024 年 5 月 23 日 至 2024 年 5 月 23 日 采用上海证券交易所网络投票系统,通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段,即 9:15-9:25,9:30-11:30,13:00-15:00;通过 互联网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 (六)融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 涉及融资融券、转融通业 ...
华阳新材:华阳新材关于参加山西辖区上市公司2024年投资者网上集体接待日暨年报业绩说明会的公告
2024-05-13 09:58
038 山西华阳新材料股份有限公司 关于参加山西辖区上市公司 2024 年投资者 网上集体接待日暨年报业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: ● 会议召开时间:2024 年 5 月 20 日(星期一)15:00-17:00。 证券代码:600281 证券简称:华阳新材 公告编号:临 2024- 三、参加人员 出席本次网上集体接待日活动的人员有:公司董事长、总经理、独立董事、董 事会秘书、财务总监、证券事务代表(如有特殊情况,参会人员将可能进行调 整),欢迎广大投资者积极参与。 四、投资者参加方式 投资者可登录"全景路演"网站(http://rs.p5w.net),或关注微信公众号: 全景财经,或下载全景路演 APP,参与本次互动交流,活动时间为 2024 年 5 月 20 日 (星期一)15:00-17:00。届时公司高管将在线就公司 2023 年度业绩、公司治理、 发展战略、经营状况、融资计划、股权激励和可持续发展等投资者关心的问题,与 投资者进行沟通与交流,欢迎广大投资者踊跃参与。 ...
华阳新材:华阳新材关于“历山1号基金”相关事项进展的公告
2024-05-08 10:08
一、历山 1 号基金背景概述 公司于 2016 年 12 月 29 日投资 2,000 万元人民币认购历山 1 号基金,该基金以 募集资金定向投资沁水历山 35.66%股权,并委托其中一名基金持有人山西高新普惠 旅游文化发展有限公司(以下简称:"普惠旅游")代持相应股权并根据基金管理 人的明确指令代为行使公司法与公司章程授予股东的权利。 证券代码:600281 证券简称:华阳新材 公告编号:临 2024- 037 山西华阳新材料股份有限公司 关于"历山 1 号基金"相关事项进展的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 近日,山西华阳新材料股份有限公司(以下简称:"公司")收到"中医药泛 旅游基金——历山项目 1 号"(以下简称:"历山 1 号基金")基金管理人上海晋 燃惠赋投资管理有限公司(以下简称:"晋燃惠赋")转来的沁水历山旅游开发有 限公司(以下简称:"沁水历山")解散纠纷案二审的民事判决书【(2024)晋 05 民 终 224 号】。具体公告如下: 3、本判决为终审判决。 三、历山 1 号基金相关事项对公 ...
华阳新材(600281) - 2024 Q1 - 季度财报
2024-04-29 08:13
Financial Performance - The company's operating revenue for Q1 2024 was CNY 41,836,553.69, a decrease of 51.95% compared to CNY 87,069,058.77 in the same period last year[5]. - The net loss attributable to shareholders for Q1 2024 was CNY -25,868,125.23, with a basic and diluted earnings per share of CNY -0.0503[5][6]. - In Q1 2024, the company reported a net profit of -25,868,125.23 RMB, compared to -28,632,442.64 RMB in Q1 2023, indicating an improvement of approximately 8.8% year-over-year[24]. - Operating profit for Q1 2024 was -23,918,998.80 RMB, an improvement from -31,993,950.29 RMB in the same period last year, reflecting a year-over-year improvement of about 25.2%[24]. - The company’s total comprehensive income for Q1 2024 was -25,868,125.23 RMB, compared to -28,632,442.64 RMB in Q1 2023, showing an improvement of about 8.8%[24]. Assets and Liabilities - The company's total assets increased by 1.55% to CNY 992,343,887.45 compared to CNY 977,234,567.61 at the end of the previous year[6]. - Total assets as of March 31, 2024, were CNY 992,343,887.45, an increase of 1.3% from CNY 977,234,567.61 at the end of 2023[20]. - Total liabilities as of March 31, 2024, were CNY 772,522,022.82, an increase of 5.6% from CNY 731,544,577.75 at the end of 2023[19]. - Long-term borrowings increased to CNY 424,770,000.00 as of March 31, 2024, compared to CNY 379,770,000.00 at the end of 2023, reflecting a growth of 11.8%[19]. - The total equity attributable to shareholders as of March 31, 2024, was CNY 219,821,864.63, a decrease of 10.5% from CNY 245,689,989.86 at the end of 2023[20]. Cash Flow - The net cash flow from operating activities was CNY -8,520,870.96, showing a significant improvement from CNY -58,634,179.45 in the previous year[6]. - Cash flow from operating activities showed a net outflow of -8,520,870.96 RMB in Q1 2024, compared to -58,634,179.45 RMB in Q1 2023, marking a significant improvement of approximately 85.5%[28]. - The company received cash from operating activities totaling 68,557,311.47 RMB in Q1 2024, compared to 56,409,127.99 RMB in Q1 2023, representing an increase of about 21.6%[28]. - Total cash and cash equivalents at the end of Q1 2024 were 71,894,421.67 RMB, down from 149,426,097.15 RMB at the end of Q1 2023[29]. - The company reported a total cash inflow from financing activities of 95,500,000.00 RMB in Q1 2024, down from 250,000,000.00 RMB in Q1 2023, a decrease of approximately 61.8%[29]. Expenses - The company reported a 37.52% increase in selling expenses due to increased salaries for sales personnel related to PBAT and product business[11]. - The company incurred research and development expenses of 567,745.54 RMB in Q1 2024, with no comparative figure provided for Q1 2023[24]. - The company’s financial expenses increased to 5,290,716.55 RMB in Q1 2024 from 4,043,982.53 RMB in Q1 2023, reflecting an increase of approximately 30.8%[24]. - The company’s sales expenses rose to 1,248,990.86 RMB in Q1 2024, compared to 908,210.65 RMB in Q1 2023, indicating an increase of about 37.5%[24]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 30,190[12]. - The equity attributable to shareholders decreased by 10.53% to CNY 219,821,864.63 from CNY 245,689,989.86 at the end of the previous year[6].
华阳新材:华阳新材2023年年度审计报告
2024-04-19 09:56
山西华阳新材料股份有限公司 中兴财光华审会字(2024)第 213099 号 审计报告 中兴财光华审会字(2024)第213099号 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台(http://acc.mcf.gov.cn) 进行查局 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台(http://acc_ 报告编码: 京24P0524P08 | . | | | | --- | --- | --- | | . | . 1 | B 1 | 审计报告 | 合并及公司资产负债表 | 1-2 | | --- | --- | | 合并及公司利润表 | 3 | | 合并及公司现金流量表 | 4 | | 合并及公司股东权益变动表 | 5-8 | | 财务报表附注 | 9-104 | 山西华阳新材料股份有限公司全体股东: 一、审计意见 我们审计了山西华阳新材料股份有限公司(以下简称华阳新材公司)财务 报表,包括 2023年 12月 31 目的合并及公司资产负债表,2023年度的合并及公 司利润表、合并及公司现金流量表、合并及公司股东权益变动表以及财务报表 附注。 我们认为,后附的财务报表在所有重大方面按照 ...
华阳新材:华阳新材2023年度独立董事述职报告(季君晖)
2024-04-19 09:55
季君晖,男,1969 年出生,浙江仙居人,中共党员,中 华人民共和国国籍,无境外永久居留权,博士研究生学历, 应用化学博士学位。1997 年 9 月至 1999 年 9 月,中国科学 院化学研究所博士后;1999 年 10 月至 1999 年 12 月,中国 科学院化学研究所副研究员;1999 年 1 月至 2005 年 10 月, 中国科学院理化技术研究所副研究员;2005 年 11 月至今, 中国科学院理化技术研究所研究员。现任本公司独立董事。 山西华阳新材料股份有限公司 2023 年度独立董事述职报告 作为公司独立董事,本人严格根据《上市公司独立董事 管理办法》《上海证券交易所上市公司自律监管指引第 1 号 —规范运作》以及《山西华阳新材料股份有限公司章程》(以 下简称"《公司章程》")等规则及公司制度规定,独立客观、 勤勉尽责地履行职责,积极参加公司召开的相关会议,认真 审议公司的各项议案,并对相关事项发表独立意见,切实维 护了公司整体利益和全体股东,尤其是中小股东的合法权益。 现将 2023 年度履职情况汇报如下: 一、独立董事的基本情况 料等相关信息,认真审议相关议案,审慎决策并发表意见。 具体会 ...
华阳新材(600281) - 2023 Q4 - 年度财报
2024-04-19 09:53
Financial Performance - The company's operating revenue for 2023 was CNY 270,551,021.40, a decrease of 17.49% compared to CNY 327,906,875.70 in 2022[22] - The net profit attributable to shareholders for 2023 was a loss of CNY 199,674,603.62, compared to a loss of CNY 36,728,952.82 in 2022[22] - The net cash flow from operating activities for 2023 was a negative CNY 144,738,856.11, indicating a significant decline in cash generation[22] - The total assets of the company decreased by 9.29% to CNY 977,234,567.61 in 2023 from CNY 1,077,373,797.20 in 2022[22] - The net assets attributable to shareholders dropped by 45.00% to CNY 245,689,989.86 in 2023 from CNY 446,734,960.15 in 2022[22] - The basic earnings per share for 2023 was -0.3882, compared to -0.0714 in 2022[22] - The weighted average return on net assets for 2023 was -57.54%, a decrease of 49.64 percentage points from -7.90% in 2022[22] - The company reported a total revenue of 270.55 million yuan, a decrease of 12% compared to the previous year, primarily due to reduced demand in the precious metals sector[61] - The net profit attributable to shareholders was -199.67 million yuan, reflecting a decline of 16.3 million yuan year-on-year[63] Operational Challenges - The company is facing significant operational risks and has outlined potential challenges in its future development strategy[9] - The company has not announced any new product developments or market expansion strategies in the current report[9] - The net profit attributable to shareholders decreased by CNY 162.95 million compared to the same period last year, primarily due to a CNY 61.72 million reduction in precious metals business profit and increased management expenses of CNY 10.31 million[26] - The company reported a net cash flow from operating activities of CNY -58.63 million for the first quarter of 2023[31] - The company has not experienced significant changes in competition or independence due to the actions of controlling shareholders, maintaining operational independence[128] Strategic Developments - The company acquired 100% equity of a biotechnology company from Shanxi Huaxu Logistics Co., Ltd. to promote transformation and development, effective from April 2023[25] - The company has strengthened operational management and achieved breakthroughs in production capacity during the reporting period[38] - The marketing system has been improved, leading to new advancements in market expansion[39] - The company established strategic partnerships with multiple clients in the biodegradable materials sector, securing substantial orders[44] - The company has successfully developed a full industrial chain for biodegradable materials, enhancing its market position[59] Research and Development - R&D expenses increased due to heightened investment in precious metals business innovation[66] - The company reported a significant increase in research and development expenses, amounting to 601,671.37 CNY, compared to zero in the previous year[71] - The company has achieved 6 innovation results and applied for 2 utility model patents since 2020, enhancing its research and development capabilities[104] - The company is actively participating in the drafting of industry standards for biodegradable materials, with 7 standards published on the national standards website[106] Governance and Compliance - The company has committed to maintaining compliance with corporate governance standards as outlined in the relevant regulatory documents[125] - The company has not identified any significant discrepancies between its governance practices and the regulations set forth by the China Securities Regulatory Commission[131] - The company is focused on enhancing its governance structure to protect the interests of all shareholders and ensure compliance with legal obligations[130] - The company has not reported any changes in controlling shareholders during the reporting period[173] - The company has not experienced any changes in shareholding for its directors and supervisors during the reporting period[139] Shareholder Relations - The company held 4 shareholder meetings during the reporting period, ensuring equal rights for all shareholders, especially minority shareholders, through a combination of on-site and online voting[121] - The total pre-tax remuneration for the board members during the reporting period amounted to 294.09 million CNY[141] - The company has maintained a consistent board structure with no changes in the number of directors or supervisors during the reporting period[139] - The company has not disclosed any related party transactions among the top shareholders[171] Financial Management - The net cash flow from financing activities increased significantly by 275.77% to 151,992,443.39 CNY, mainly due to increased borrowings[74] - Long-term borrowings increased by 89.82% to CNY 379.77 million, mainly due to new mid-term bank loans[96] - The company has committed to improving its internal control and risk management practices as highlighted in the internal control evaluation report[157] - The company plans to hold a temporary shareholders' meeting to discuss the third quarter report and other significant matters[158]
华阳新材:华阳新材董事会对独立董事独立性自查情况的专项报告
2024-04-19 09:53
山西华阳新材料股份有限公司 董事会对独立董事独立性自查情况的 专项报告 山西华阳新材料股份有限公司董事会 2024 年 4 月 18 日 根据中国证券监督管理委员会《上市公司独立董事管理 办法》、上海证券交易所《股票上市规则》《上市公司自律 监管指引第 1 号——规范运作》和《公司章程》《公司独立 董事工作制度》等有关规定,山西华阳新材料股份有限公司 (以下简称"公司")董事会就公司现任独立董事杨志军先 生、季君晖先生、上官泽明先生的独立性情况进行评估并出 具如下专项意见: 经核查独立董事杨志军先生、季君晖先生、上官泽明先 生的任职经历以及签署的相关自查文件,上述人员未在公司 担任除独立董事以外的任何职务,也未在公司主要股东公司 担任任何职务,与公司以及主要股东之间不存在利害关系或 其他可能妨碍其进行独立客观判断的关系,不存在影响独立 董事独立性的情况,符合对独立董事独立性的相关要求。 ...